Results 151 to 160 of about 4,714 (209)

P450 engineering via structure-guided rational design achieves high C21-selectivity and bioconversion in steroid biosynthesis. [PDF]

Synth Syst Biotechnol
Yang J, Li R, Gao Q, Ma L, Wang Q, Ma G, Fan Y, Li S, Xu LH.   +8 more
europepmc   +1 more source

Unmasking the risk: clinical trials versus real-world evidence on dydrogesterone and birth defects. [PDF]

Hum Reprod Open
Parazzini F, Cantarutti A, Esposito G.
europepmc   +1 more source

Pregnancy Rate Is High When the Length of the Luteal Phase During the In Vitro Fertilization Hormone Replacement Cycle Is 144 Hours or More Before Embryo Transfer. [PDF]

Cureus
Nishio E, Oikawa S, Sakakibara E, Ishikawa M, Kotani K, Yoshizawa H, Miyamura H, Hayashi T, Nishizawa H.   +8 more
europepmc   +1 more source

Birth defects reporting and the use of dydrogesterone: a disproportionality analysis from the World Health Organization pharmacovigilance database (VigiBase). [PDF]

Hum Reprod Open
Henry A, Santulli P, Bourdon M, Maignien C, Chapron C, Treluyer JM, Guibourdenche J, Chouchana L.   +7 more
europepmc   +1 more source

Oral dydrogesterone versus oral micronized progesterone in threatened miscarriage: protocol paper for a randomized controlled trial. [PDF]

Reprod Fertil
Kriplani A, Kamilya GS, Devi TR, Taneja A, Pawar A, Nagesh GK, Pattanaik T, Gupta T, Jain M, Mitra M.   +9 more
europepmc   +1 more source

Study on the relationship between endometrial thickness on the hCG day in the progestin-primed ovarian stimulation protocol and pregnancy outcomes in frozen-thawed embryo transfer cycles. [PDF]

Front Endocrinol (Lausanne)
Wang Y, Chang Y, Zhuang S, Zeng H, Liang X.   +4 more
europepmc   +1 more source

Real-World Evidence of Dydrogesterone 20 mg and 30 mg SR Usage in Pregnancy. [PDF]

Cureus
Manickavasagam M, Vakil A, Singh E, Roy H, Lal N, Patel RG, Mishra R, Gudibanda S, Shah S.   +8 more
europepmc   +1 more source

Oral dydrogesterone along with vaginal micronized progesterone supplementation for luteal phase support in IVF patients, and its impact on pregnancy and live birth rates: a prospective randomized trial. [PDF]

BMC Pregnancy Childbirth
Rinaldi L, Crescenzi F, Selman H.
europepmc   +1 more source

Comparing Dydrogesterone Versus Medroxyprogesterone in Progestin-Primed Ovarian Stimulation (PPOS) for Patients Undergoing In Vitro Fertilization/Intracytoplasmic Sperm Injection: A Systematic Review. [PDF]

Cureus
Muharam R, Nurdya AN, Yo EC, Sumapraja K, Harzif AK, Maidarti M, Wiweko B, Hestiantoro A.   +7 more
europepmc   +1 more source

Multisystem challenges in reproductive medicine: A case report of bicornuate uterus, fibroadenoma, and postpartum thyroiditis. [PDF]

Medicine (Baltimore)
Faisal F, Javed A, Muzaffar F, Patel T, Ibrahim A, Henna F, Siddiqui HT, Daishik Patel B, Sardarova N, Anand N.   +9 more
europepmc   +1 more source